Hims & Hers will start selling a generic weight loss drug
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The news comes as some patients still struggle to fill prescriptions of the most advanced branded GLP-1 treatments on the market like Zepbound,
Hims & Hers Health plans to offer generic version of Novo Nordisk's drug
Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month
Hims & Hers to sell generic weight loss drug in 2025
Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.
Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025
Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a generic version of a Novo Nordisk diabetes and weight-loss drug as early as next year.
Hims & Hers Stock Jumps. A Generic Version of Novo Nordisk Diabetes Drug Is Close.
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo Nordisk’s diabetes drug as soon as 2025. It reported strong quarterly earnings.
Hims & Hers Stock Rises on Earnings and Planned Generic Version of Novo Nordisk Diabetes Drug
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...
Seeking Alpha3h
Novo Nordisk: A GLP-1 Leader Faces Increasing Competition
Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. Intense ...
kffhealthnews14h
Lawsuits Say GoodRx, PBMs Quash Reimbursements To Small Pharmacies
CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...
Morningstar1d
Hims & Hers Health Inc Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
California Healthline2mon
California Healthline Daily Edition
Whoever wins the presidency, the 2024 election has outsized implications for California. The elevation of Democratic Vice President Kamala Harris to the highest office in the land would make her the ...
Fatty Liver Disease: What Men Need to Know
Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.
Business Insider6d
Hims & Hers falls -14.6%
Hims & Hers (HIMS) is down -14.6%, or -$3.25 to $19.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks ...
Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.